Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 805 results for "scientific outlook"

Boston Scientific (BSX) Stock Jumps on Q1 Results, Raised Outlook

NEW YORK (TheStreet) -- Shares of Boston Scientific Corp. (BSX - Get Report) are spiking by 8.89% to $21.42 on Wednesday morning, after the Marlborough, MA-based company posted better-than-expected results for the 2016 first quarter. Before today's ... TheStreet.com, 5 days ago
[x]  
Zacks.com

Thermo Fisher (TMO) Beats on Q1 Earnings, Raises Outlook

Thermo Fisher Scientific, Inc. TMO reported better-than-expected first-quarter 2016 financial results. Adjusted earnings per share (EPS) in the quarter came in at $1.80, 3.4% ahead of the Zacks Consensus Estimate and higher than the year-ago quarter ...
 Zacks.com4 days ago Thermo Fisher Scientific (TMO) Showing Signs Of Being Water-Logged And Getting Wetter  TheStreet.com4 days ago
[x]  
Proactive Investors.co.uk

United States Electrophysiology Devices Market Outlook to 2021 - Key Players are Biosense Webster, Medtronic & Boston Scientific Corporation - Research and Markets

Research and Markets has announced the addition of the "United States Electrophysiology Devices Market Outlook to 2021" report to their offering. The report provides key market data on the United States Electrophysiology Devices market. The data in ...
 4 Traders1 week ago BioSig Technologies to Attend Heart Rhythm Society???s 37th Annual Scientific Sessions, May 4-7, 2016 in San Francisco, CA  Consumer Electronics Net5 days ago Global Oncology Ablation Market Outlook: 2015-2020 (2nd Edition)  BioSpace6 days ago Spain Electrophysiology Devices Market Outlook to 2021  International Business Times4 days ago
[x]  
Nasdaq

Boston Scientific Sees Q2 Results In Line With View; Lifts FY16 Outlook

The company estimates sales for the second quarter of 2016 to be in a range of $2.010 to $2.060 billion, which versus the prior year period represents growth of approximately 9 to 12 percent on a reported basis, growth of approximately 11 to 13 ...
 Nasdaq5 days ago
Nasdaq

Eurofins Scientific Q1 Revenues Climb; Confirms Positive Outlook

Organic growth was over 10 percent in the first quarter, following a strong organic growth of over 9.5 percent in the final quarter of 2015. The remainder of the revenue growth was made up of contribution from acquisitions, with neutral currency ...
 Nasdaq1 week ago Eurofins Achieves 48% Revenue Growth and over 10% Organic Growth in Q1 2016 - HTML (w)  WorldRegInfo1 week ago
[x]  

Fitch Affirms Boston Scientific's IDR at 'BBB-'; Outlook Stable

Fitch Ratings has affirmed Boston Scientific Corp.'s (NYSE: BSX) long-term Issuer Default Rating (IDR) at 'BBB-'. The Rating Outlook is Stable. A full list of BSX's ratings follows at the end of this release. The rating action applies to ...
 4 Traders1 week ago
[x]  

Global Mice Model (Model, Products, and Services) Market Outlook: 2015-2021

/PRNewswire/ -- Using animals in the laboratory to conduct numerous scientific tests has been a traditional practice in the entire science community across the globe. Animals in laboratory are used for research & investigation of numerous diseases ...
 Sys-Con Media1 week ago
[x]  

New Science Puts Decline of Pacific Bluefin at 97.4 Percent

The outlook just got worse for the world's most endangered tuna. A new assessment shows that the Pacific bluefin tuna population, estimated a few years ago to have declined by 96.4 percent from its historic, unfished size, has continued to drop. ...
 The Pew Charitable Trusts1 week ago Sushi alert: Grim outlook for bluefin tuna  Shortwave IT!1 week ago Food › Sushi alert: Grim outlook for bluefin tuna  Shortwave IT!1 week ago

Gilead Sciences (GILD) John F. Milligan on Q1 2016 Results - Earnings Call Transcript

Gilead Sciences, Inc. (NASDAQ: GILD ) Q1 2016 Earnings Call April 28, 2016 4:30 pm ET Executives Patrick O'Brien - Senior Director-Investor Relations John F. Milligan - President, Chief Executive Officer & Director Robin L.
 Seeking Alpha3 days ago AMETEK (AME) Frank Hermance on Q1 2016 Results - Earnings Call Transcript  Seeking Alpha2 days ago Amgen (AMGN) Robert A. Bradway on Q1 2016 Results - Earnings Call Transcript  Seeking Alpha3 days ago Automatic Data Processing (ADP) Carlos A. Rodriguez on Q3 2016 Results - Earnings Call Transcript  Seeking Alpha3 days ago

Boston Scientific's first-quarter results beat estimates, stock rises [Star Tribune (Minneapolis)]

April 28--Unexpectedly strong sales of stents and other products for blocked blood vessels at Boston Scientific Corp. overcame continued weakness in heart-rhythm devices, driving the company to its best quarterly sales growth in a decade. Boston ...
 Bloomberg4 days ago BOSTON SCIENTIFIC : first-quarter results beat estimates, stock rises  4 Traders4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less